Manana Elia

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler et al. · Breast Cancer Research and Treatment · 2014 · 215 citations · Full text

Life Sciences, Genetics, Oncology +14

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Priyanka Sharma, Vandana G. Abramson, Anne O’Dea et al. · Clinical Cancer Research · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Rachel Yoder, Bruce F. Kimler, Joshua M. Staley et al. · npj Breast Cancer · 2022 · 74 citations · Full text

Medicine, Oncology, Breast Oncology +13

Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial).

Qamar J. Khan, Anne O’Dea, Aditya Bardia et al. · Journal of Clinical Oncology · 2020 · 68 citations

Medicine, Oncology, Pharmacology +17